The Haemophilia Foundation of New Zealand has renewed calls for a public inquiry into the past management of the national blood system. The renewed call came after it was revealed three New Zealanders are among 1500 plaintiffs world-wide in a class action against major American pharmaceutical companies over the use of blood products taken from high-risk populations such as prison inmates, intravenous drug-users and urban homosexual communities, claiming they were exposed to HIV and hepatitis C. The haemophiliacs received the potentially contaminated imported blood-clotting agents in the 1970s and 1980s. Foundation president Mike Carnahan said it was high time the...